Found: 63
Select item for more details and to access through your institution.
Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing–remitting multiple sclerosis?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5810
- By:
- Publication type:
- Article
Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 9, p. 1175, doi. 10.1002/pds.4839
- By:
- Publication type:
- Article
Critically reviewing impact of regulatory actions, not just FDA's.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 1, p. 105, doi. 10.1002/pds.3509
- By:
- Publication type:
- Article
Comparison of potential risk factors for medication errors with and without patient harm.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 8, p. 825, doi. 10.1002/pds.1977
- By:
- Publication type:
- Article
Reliability of the assessment of preventable adverse drug events in daily clinical practice.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 7, p. 645, doi. 10.1002/pds.1586
- By:
- Publication type:
- Article
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder preconvention questionnaire.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2217543
- By:
- Publication type:
- Article
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 19, doi. 10.1111/dom.13453
- By:
- Publication type:
- Article
Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry‐based study.
- Published in:
- Haemophilia, 2020, v. 26, n. 5, p. 809, doi. 10.1111/hae.14100
- By:
- Publication type:
- Article
Computerized physician order entry (CPOE) system: expectations and experiences of users.
- Published in:
- Journal of Evaluation in Clinical Practice, 2010, v. 16, n. 4, p. 738, doi. 10.1111/j.1365-2753.2009.01187.x
- By:
- Publication type:
- Article
Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Comment on: "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022".
- Published in:
- 2024
- By:
- Publication type:
- Letter
The Influence that Electronic Prescribing Has on Medication Errors and Preventable Adverse Drug Events: an Interrupted Time-series Study.
- Published in:
- Journal of the American Medical Informatics Association, 2009, v. 16, n. 6, p. 816, doi. 10.1197/jamia.M3099
- By:
- Publication type:
- Article
A full-document analysis of the semantic relation between European Public Assessment Reports and EMA guidelines using a BERT language model.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0294560
- By:
- Publication type:
- Article
Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 4, p. 297, doi. 10.1007/s00228-005-0058-y
- By:
- Publication type:
- Article
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01031
- By:
- Publication type:
- Article
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 3, p. 243, doi. 10.1007/s40264-022-01270-4
- By:
- Publication type:
- Article
Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach.
- Published in:
- Drug Safety, 2022, v. 45, n. 4, p. 369, doi. 10.1007/s40264-022-01149-4
- By:
- Publication type:
- Article
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.
- Published in:
- Drug Safety, 2021, v. 44, n. 8, p. 853, doi. 10.1007/s40264-021-01081-z
- By:
- Publication type:
- Article
Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 73, doi. 10.1007/s40264-020-00995-4
- By:
- Publication type:
- Article
Correction to: Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".
- Published in:
- 2019
- By:
- Publication type:
- letter
Correction to: Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 12, p. 2864, doi. 10.1093/jac/dkr366
- By:
- Publication type:
- Article
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 4, p. 550, doi. 10.1093/jac/dki037
- By:
- Publication type:
- Article
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.662642
- By:
- Publication type:
- Article
A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.626766
- By:
- Publication type:
- Article
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.617409
- By:
- Publication type:
- Article
Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0235048
- By:
- Publication type:
- Article
The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Anticoagulant medication errors in hospitals and primary care: a cross-sectional study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Understanding drug preferences, different perspectives.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 6, p. 978, doi. 10.1111/bcp.12566
- By:
- Publication type:
- Article
Additional safety risk to exceptionally approved drugs in Europe?
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 3, p. 490, doi. 10.1111/j.1365-2125.2011.03995.x
- By:
- Publication type:
- Article
Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Healthcare Professionals' Self-Reported Experiences and Preferences Related to Direct Healthcare Professional Communications. A Survey Conducted in the Netherlands.
- Published in:
- Drug Safety, 2012, v. 35, n. 11, p. 1061, doi. 10.2165/11635750-000000000-00000
- By:
- Publication type:
- Article
Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Impact of safety-related regulatory action on clinical practice: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article